Evidence map›Paper›PMID 36263866›Full record

ReviewAnnals of medicine2022

A literature perspective on the pharmacological applications of yohimbine.

Nasimudeen R Jabir, Chelapram K Firoz, Torki A Zughaibi, Mohammed Abdullah Alsaadi, Adel M Abuzenadah, Ahmed Ibrahim Al-Asmari, Ahdab Alsaieedi, Bakrudeen Ali Ahmed, Arun Kumar Ramu, Shams Tabrez

Open access · goldAbstract readReview
In one paragraph

Review in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Mechanism of ginsenoside RbBiomedical reports · 2024
    Article
  16. Multifaced Nature of Yohimbine-A Promising Therapeutic Potential or a Risk?International journal of molecular sciences · 2024
    Review
  17. Targeting αEnvironmental toxicology and pharmacology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Nasimudeen R JabirDepartment of Biochemistry and Biotechnology, Centre for Research and Development, PRIST University, Vallam, Thanjavur, India.
Chelapram K FirozDepartment of Medical Laboratory Technology, MIMS College of Allied Health Sciences, ASTER MIMS Academy, Malappuram, Kerala University of Health Sciences, Kerala, India.
Torki A ZughaibiToxicology and Forensic Science Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammed Abdullah AlsaadiHematology Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Adel M AbuzenadahToxicology and Forensic Science Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahmed Ibrahim Al-AsmariToxicology and Forensic Science Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Ahdab AlsaieediDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Bakrudeen Ali AhmedDepartment of Biochemistry and Biotechnology, Centre for Research and Development, PRIST University, Vallam, Thanjavur, India.
Arun Kumar RamuDepartment of Biochemistry and Biotechnology, Centre for Research and Development, PRIST University, Vallam, Thanjavur, India.
Shams TabrezToxicology and Forensic Science Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0003-4550-415X
King Abdulaziz University · SAPRIST University · INKerala University of Health Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenergic alpha-AntagonistsAphrodisiacsHumansMalePharmaceutical PreparationsReceptors, Adrenergic, alpha-2YohimbineAdrenergic alpha-AntagonistsAphrodisiacsPharmaceutical PreparationsReceptors, Adrenergic, alpha-2Yohimbineindole alkaloidpharmacologyphytochemicalYohimbineα2-receptor antagonist

Identifiers

PMID36263866
PMCPMC9590431
OpenAlexW4306869219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.